glp 1 reviews and complaints elara GLP-1 is not just a weight loss trend it's a medical Gala Health GLP-1 Review 2026:

Los agonistas GLP-1 (semaglutida, liraglutida, dulaglutida, tirzepatida) actan estimulando la secrecin de insulina, suprimiendo glucagn, retrasando el vaciamiento gstrico y reduciendo el apetito

Studies with liraglutide have shown mixed results, with some suggesting potential benefits alongside modest motor effects, though robust evidence for cognitive improvements is currently lacking

In 3,533 adults with type 2 diabetes and chronic kidney disease, semaglutide 1.0 mg reduced the primary composite kidney outcome by 24%

Obesity also increases the risk of cardiovascular disease, where 5 kg increases in weight in adults is associated with an 11% higher risk of death from cardiovascular disease (strokes, coronary heart disease, myocardial infarction etc)

Ma RL, Deng Y, Wang YF, Zhu SY, Ding XS, Sun AJ